| | | Single nucleotide variant (missense variant) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +2 more | GConflicting classifications of pathogenicity |
| | | Duplication (intron variant) | Familial isolated pituitary adenoma +4 more | |
| | | Single nucleotide variant (intron variant) | Neuroblastoma, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Familial isolated pituitary adenoma +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 | |
| | | Single nucleotide variant (intron variant) | Neuroblastoma, susceptibility to, 3 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Familial isolated pituitary adenoma +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial isolated pituitary adenoma +1 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +2 more | |
| | | Single nucleotide variant (missense variant) | Neuroblastoma, susceptibility to, 3 +2 more | |
| | | Single nucleotide variant (missense variant) | Familial isolated pituitary adenoma | |